Stocks and Investing
Stocks and Investing
Thu, November 2, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew O"Brien Downgraded (ZBH) to Hold on, Nov 2nd, 2017
Matthew O"Brien of Piper Sandler, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold on, Nov 2nd, 2017.
Matthew has made no other calls on ZBH in the last 4 months.
There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 1 agrees with Matthew"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;
Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold on, Friday, July 28th, 2017
These are the ratings of the 3 analyists that currently disagree with Matthew;
Jennie Tsai of "Gabelli & Co." Initiated at Strong Buy on, Thursday, August 24th, 2017 Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Friday, July 28th, 2017 Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017